Cargando…
Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis
BACKGROUND: Lymphangioleiomyomatosis is a rare disease occurring almost exclusively in women. Diagnosis often requires surgical biopsy and the clinical course varies between patients with no predictors of progression. We evaluated recent diagnostic guidelines, clinical features and serum biomarkers...
Autores principales: | Chang, William YC, Cane, Jennifer L, Blakey, John D, Kumaran, Maruti, Pointon, Kate S, Johnson, Simon R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431996/ https://www.ncbi.nlm.nih.gov/pubmed/22513045 http://dx.doi.org/10.1186/1465-9921-13-34 |
Ejemplares similares
-
Lymphangioleiomyomatosis: Searching for potential biomarkers
por: Revilla-López, Eva, et al.
Publicado: (2023) -
Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis
por: Hirose, Masaki, et al.
Publicado: (2019) -
The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
por: Gaffney, Brian, et al.
Publicado: (2021) -
Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014) -
Lymphangioleiomyomatosis (LAM)
Publicado: (2017)